Below are the financial statements of Elevance Health, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 8,288a | 6,526a |
| Fixed maturity securities (amortized cost of $25,879 and $30,446; allowance for credit losses of $6 and $4) | 25,201a | 29,614a |
| Equity securities | 1,192a | 229a |
| Premium receivables | 8,011a | 7,902a |
| Self-funded receivables | 5,044a | 4,558a |
| Other receivables | 6,016a | 5,405a |
| Other current assets | 4,700a | 5,795a |
| Assets held for sale | 490a | 0a |
| Total current assets | 58,942a | 60,029a |
| Long-term investments | — | — |
| Fixed maturity securities (amortized cost of $1,049 and $890; allowance for credit losses of $0 and $0) | 1,035a | 876a |
| Other invested assets | 9,749a | 6,107a |
| Property and equipment, net | 4,652a | 4,359a |
| Goodwill | 28,277a | 25,317a |
| Other intangible assets | 12,094a | 10,273a |
| Other noncurrent assets | 2,140a | 1,967a |
| Total assets | 116,889a | 108,928a |
| Liabilities and equity | — | — |
| Liabilities | — | — |
| Current liabilities | — | — |
| Medical claims payable | 15,746a | 16,111a |
| Other policyholder liabilities | 4,204a | 5,600a |
| Unearned income | 1,508a | 1,402a |
| Accounts payable and accrued expenses | 6,927a | 6,910a |
| Short-term borrowings | 365a | 225a |
| Current portion of long-term debt | 1,649a | 1,649a |
| Other current liabilities | 10,029a | 9,894a |
| Liabilities held for sale | 153a | 0a |
| Total current liabilities | 40,581a | 41,791a |
| Long-term debt, less current portion | 29,218a | 23,246a |
| Reserves for future policy benefits | 190a | 778a |
| Deferred tax liabilities, net | 2,148a | 1,970a |
| Other noncurrent liabilities | 3,326a | 1,738a |
| Total liabilities | 75,463a | 69,523a |
| Shareholders’ equity | — | — |
| Preferred stock, without par value, shares authorized - 100,000,000; shares issued and outstanding - none | 0a | 0a |
| Common stock, par value $0.01, shares authorized - 900,000,000; shares issued and outstanding - 227,479,695 and 233,071,088 | 2a | 2a |
| Additional paid-in capital | 8,911a | 8,868a |
| Retained earnings | 33,549a | 31,749a |
| Accumulated other comprehensive loss | -1,147a | -1,313a |
| Total shareholders’ equity | 41,315a | 39,306a |
| Noncontrolling interests | 111a | 99a |
| Total equity | 41,426a | 39,405a |
| Total liabilities and equity | 116,889a | 108,928a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.